Our Cellular Therapy and Stem Cell General FAQ

General Cellular Therapy and Stem Cell FAQ at Dr. StemCellsThailand’s Anti-Aging and Regenerative Medicine Center in Thailand

What are Cellular Therapy and Stem Cells?

Cellular Therapy and Stem Cells are primitive, unspecialized cells recognized for their unique ability to differentiate into various cell types, tissues, and organs. Their remarkable properties, including self-renewal and the capacity to repair injuries, make them invaluable in Anti-Aging and Regenerative Medicine. Over a century of research has demonstrated that these cells can transform into multiple lineages, such as skin cells, blood cells, and even lung or heart tissue, which is crucial for treating conditions like chronic obstructive pulmonary disease (COPD), heart disease, diabetes, neurological disorders (such as Parkinson’s and Alzheimer’s), and musculoskeletal injuries. Additionally, stem cells have shown therapeutic potential in treating autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, as well as in regenerative therapies for conditions affecting the liver and kidneys.

Where is Dr. StemCellsThailand’s Cellular Therapy and Stem Cell Banking and Laboratory located?

Our Cellular Therapy and Stem Cell banking and laboratory is located at the Thailand Science Park, a hub for innovation and technology. This location ensures adherence to the highest standards in Cellular Therapy and Stem Cell clinical trials, research and therapy.

What technologies and standards do Dr. StemCellsThailand utilize?

Dr. StemCellsThailand’s Anti-Aging and Regenerative Medicine Center utilizes internationally accredited, patented technology to meet every Cellular Therapy and Stem cell’s need. We guarantee that every procedure is painless, scarless, and entirely safe. Our facility is fully equipped with state-of-the-art technology and adheres to strict regulatory standards, ensuring that our practices meet international safety and quality benchmarks.

What services does Dr. StemCellsThailand offer?

Dr. StemCellsThailand offers Cellular Therapy and Stem Cell banking services for the whole family, with services available for all ages. We have led the industry in technical innovation, allowing us to provide the best Cellular Therapy and Stem Cell care in the business. Our operations are overseen by internationally renowned physicians of various regenerative specialties, guided by the Foundation for the Accreditation of Cellular Therapy (FACT), the Medical Council of Thailand, and a set of international medical ethics in research and development for Cellular Therapy and Stem Cell transplantation.

What is the laboratory’s compliance history?

Our laboratory has no history of regulatory violations, non-compliance, or recalls. We exceed industry standards and are certified by the National Environmental Balancing Bureau (NEBB) and ISO 9001:2008, ensuring a safe, controlled environment for the preservation of our center’s stem cells.

What types of stem cells does Dr. StemCellsThailand focus on?

We focus on the collection of two primary types of stem cells:

– Hematopoietic Stem Cells (HSCs): Found in umbilical cord blood, crucial for developing blood cells and treating blood disorders and immune system problems. They cannot be multiplied, making umbilical cord blood a rare and valuable source.

– Mesenchymal Stem Cells (MSCs): Retrieved from the placenta or excess adipose (fat) tissue, MSCs can differentiate into various cell types and can be expanded in culture, making them key in treating hundreds of disorders and useful for restorative or cosmetic procedures.

How does Dr. StemCellsThailand ensure the quality of stem cell deposits?

We offer a lifetime service for Cellular Therapy and Stem Cell storage and transportation. Unlike other stem cell banks that freeze deposits as tissue segments without verification, we verify the quantity and quality of our stem cells, ensuring there are at least 10 million cells before long-term storage. Each deposit is matched to your identity through a unique photo-certificate documenting the total cell count, stem cell type, viability, number of vials, and growth potential.

What guarantees does Dr. StemCellsThailand provide regarding stem cell quality?

We provide a 30-year guarantee on the quality of our Cellular Therapy and Stem Cells. In the unlikely event that our reports show a drop in vitality, you’ll be reimbursed ten times your service fee.

Why is early processing of stem cells critical?

Early processing enhances cell quality by minimizing contamination risks and ensuring high viability and potency. Viability refers to the cells’ ability to remain functional throughout processing and storage, while potency describes their capacity to differentiate into various cell types. Both factors are essential for effective therapies.

What is Graft vs. Host Disease (GvHD) and how does Dr. StemCellsThailand mitigate this risk?

Graft vs. Host Disease (GvHD) is a potential complication in allogeneic stem cell transplants where the recipient’s immune system attacks the donor cells. Our use of umbilical cord blood stem cells significantly reduces this risk due to their lower immunogenicity. Human Leukocyte Antigen (HLA) matching is essential for ensuring compatibility between donor and recipient.

What advantages do umbilical cord blood stem cells (USCs) have over bone marrow stem cells (BMSCs)?

Umbilical cord blood stem cells offer several advantages over bone marrow stem cells, including easier collection through a painless and non-invasive procedure, greater potency, and a lower likelihood of GvHD. They are also less likely to be contaminated with latent viruses, as they are collected from a primordial source.

What types of stem cells can be sourced, and what are their characteristics?

Stem cells can be sourced from various lineages, including:

– Embryonic Stem Cells (ESC): Extracted from early-stage embryos, not used in our facility due to ethical concerns.

– Umbilical Cord Blood Stem Cells (UCBSC): Derived from the umbilical cord, widely used in successful treatments since 1956 and at our center since 2004.

– Adult Stem Cells: Sourced from tissues such as bone marrow, peripheral blood, and adipose tissue.

What is the difference between autologous and allogeneic stem cells?

Autologous cells are derived from the patient’s own body, while allogeneic cells come from donors. Allogeneic stem cells, particularly from younger donors, often provide greater regenerative potential compared to autologous cells, which may be weakened by age or disease.

What has research shown regarding the regenerative capacity of allogeneic mesenchymal cells?

Research has shown that allogeneic mesenchymal cells from young donors have significantly greater regenerative capacity than autologous cells from older patients. While autologous stem cells play a vital role in cosmetic treatments, allogeneic cells are generally more effective for treating degenerative diseases due to their enhanced potency and viability.

What medical conditions can Cellular Therapy and Stem Cells help treat?

Cellular Therapy and Stem Cells offer significant benefits for various medical conditions, including the ability to repair tissues and treat diseases such as heart disease and lung conditions. By choosing Dr. StemCellsThailand’s Anti-Aging and Regenerative Medicine Center, patients can be assured of receiving high-quality stem cell therapies backed by extensive clinical trials, research and clinical expertise.

References

1. Blau, H. M., Brazelton, T. R., & Weimann, J. M. (2001). The evolving concept of a stem cell: entity or function. Cell, 105(7), 829-841. https://doi.org/10.1016/S0092-8674(01)00409-3
2. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., … & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. https://doi.org/10.1080/14653240600855905
3. Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., … & Keating, A. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7(5), 393-395. https://doi.org/10.1080/14653240500319234
4. Dominici, M., Pritchard, C., Garlits, J. E., Hofmann, T. J., Persons, D. A., & Horwitz, E. M. (2004). Engineered beauty: the future of regenerative medicine. Aesthestic Surgery Journal, 24(4), 380-387. https://doi.org/10.1016/j.asj.2004.06.007
5. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., … & Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. science, 284(5411), 143-147. https://doi.org/10.1126/science.284.5411.143